Comparison of the i-STAT handheld activated clotting time with the Hemochron activated clotting time during and after percutaneous coronary intervention.
Schussler
Jeffrey M
JM
Department of Cardiology, Baylor University Medical Center, Dallas, Texas, USA. JeffreSc@Baylorhealth.edu
Aguanno
James J
JJ
Glover
Elizabeth N
EN
Vish
Nancy A
NA
Wissinger
Laurie A
LA
Schumacher
John R
JR
Wheelan
Kevin R
KR
D000077284:Abciximab; D000704:Analysis of Variance; D015906:Angioplasty, Balloon, Coronary; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D003327:Coronary Disease / Q000097:blood* / Q000628:therapy*; D016903:Drug Monitoring / Q000295:instrumentation* / Q000592:standards; D000077542:Eptifibatide; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D016014:Linear Models; D010455:Peptides / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D019095:Point-of-Care Systems / Q000592:standards*; D011237:Predictive Value of Tests; D000077466:Tirofiban; D016896:Treatment Outcome; D014443:Tyrosine / Q000031:analogs & derivatives / Q000627:therapeutic use; D014914:Whole Blood Coagulation Time
D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D007140:Immunoglobulin Fab Fragments; D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D014443:Tyrosine; D006493:Heparin; D000077466:Tirofiban; D000077542:Eptifibatide; D000077284:Abciximab